The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -92.80% this year. Over the last six months, there has been a stronger performance of -87.08%. The price of BCTX leaped by -21.10% during the last 30 days period. For the last 5-days stocks have slided -11.38%.
BriaCell Therapeutics Corp (BCTX) has a current stock price of $0.65. During the previous trading session, the stock witnessed a notable rise, reaching a high of $32.0 after opening at $0.65. The stock’s low for the day was $15.0, and it eventually closed at $0.69.
BriaCell Therapeutics Corp’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $29.40 on 09/11/24, and the lowest price during that time was $0.61, recorded on 08/06/25.
52-week price history of BCTX Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. BriaCell Therapeutics Corp’s current trading price is -97.77% away from its 52-week high, while its distance from the 52-week low is 7.36%. The stock’s price range over this timeframe has been between $0.61 and $29.40. The shares of the Healthcare sector company recorded a trading volume of approximately 0.77 million for the day, which was comparatively lower than the average daily volume of 1.29 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
BriaCell Therapeutics Corp (BCTX) has experienced a quarterly decline of -81.55% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 11.49M and boasts a workforce of 18 employees.
Expert Opinions: Analysts’ Ratings for BriaCell Therapeutics Corp
As of right now, 1 analyst is rating BriaCell Therapeutics Corp as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.7357, with a change in price of -3.3151. Similarly, BriaCell Therapeutics Corp recorded 1,570,763 in trading volume during the last 100 days, posting a change of -83.50%.
BCTX Stock Stochastic Average
The raw stochastic average for BriaCell Therapeutics Corp over the last 50 days is presently at 1.50%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 21.38%. Further, the company’s Stochastic %K and %D values for the last 20 days were 34.79% and 47.32%, respectively.
